COSMOS Pharmaceutical Corporation (TYO:3349)
9,576.00
+83.00 (0.87%)
Aug 15, 2025, 3:30 PM JST
COSMOS Pharmaceutical Ratios and Metrics
Market cap in millions JPY. Fiscal year is June - May.
Millions JPY. Fiscal year is Jun - May.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Aug '25 Aug 14, 2025 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2016 - 2020 |
Market Capitalization | 758,968 | 700,001 | 502,890 | 525,081 | 483,107 | 603,094 | Upgrade
|
Market Cap Growth | 39.20% | 39.20% | -4.23% | 8.69% | -19.89% | -1.55% | Upgrade
|
Enterprise Value | 751,887 | 705,765 | 495,143 | 507,058 | 456,292 | 562,389 | Upgrade
|
Last Close Price | 9576.00 | 8832.00 | 6290.18 | 6516.74 | 5952.64 | 7389.88 | Upgrade
|
PE Ratio | 24.50 | 22.60 | 20.57 | 22.07 | 20.86 | 22.21 | Upgrade
|
Forward PE | 23.05 | 21.94 | 19.07 | 21.97 | 19.33 | 24.17 | Upgrade
|
PS Ratio | 0.75 | 0.69 | 0.52 | 0.63 | 0.64 | 0.83 | Upgrade
|
PB Ratio | 2.95 | 2.72 | 2.17 | 2.49 | 2.54 | 3.54 | Upgrade
|
P/TBV Ratio | 2.95 | 2.72 | 2.18 | 2.49 | 2.54 | 3.54 | Upgrade
|
P/FCF Ratio | - | - | - | 67.33 | - | 333.02 | Upgrade
|
P/OCF Ratio | 14.47 | 13.34 | 9.11 | 9.65 | 15.01 | 21.64 | Upgrade
|
PEG Ratio | 3.15 | 2.26 | 2.90 | 5.05 | 4.03 | 2.32 | Upgrade
|
EV/Sales Ratio | 0.74 | 0.70 | 0.51 | 0.61 | 0.60 | 0.77 | Upgrade
|
EV/EBITDA Ratio | 12.09 | 11.35 | 9.63 | 10.68 | 10.16 | 11.98 | Upgrade
|
EV/EBIT Ratio | 18.83 | 17.67 | 15.72 | 16.83 | 15.31 | 16.97 | Upgrade
|
EV/FCF Ratio | -875.30 | - | - | 65.02 | - | 310.54 | Upgrade
|
Debt / Equity Ratio | 0.19 | 0.19 | 0.15 | 0.09 | 0.05 | 0.06 | Upgrade
|
Debt / EBITDA Ratio | 0.80 | 0.80 | 0.66 | 0.38 | 0.21 | 0.22 | Upgrade
|
Debt / FCF Ratio | - | - | - | 2.33 | - | 5.77 | Upgrade
|
Asset Turnover | 2.02 | 2.02 | 2.15 | 2.11 | 2.15 | 2.20 | Upgrade
|
Inventory Turnover | 8.94 | 8.94 | 9.49 | 9.16 | 9.52 | 10.19 | Upgrade
|
Quick Ratio | 0.31 | 0.31 | 0.30 | 0.29 | 0.28 | 0.39 | Upgrade
|
Current Ratio | 0.75 | 0.75 | 0.72 | 0.71 | 0.71 | 0.78 | Upgrade
|
Return on Equity (ROE) | 12.67% | 12.67% | 11.05% | 11.85% | 12.83% | 17.17% | Upgrade
|
Return on Assets (ROA) | 4.99% | 4.99% | 4.39% | 4.80% | 5.29% | 6.26% | Upgrade
|
Return on Capital (ROIC) | 8.71% | 8.71% | 7.96% | 8.77% | 9.78% | 12.23% | Upgrade
|
Return on Capital Employed (ROCE) | 13.10% | 13.10% | 12.00% | 13.20% | 14.80% | 18.20% | Upgrade
|
Earnings Yield | 4.08% | 4.42% | 4.86% | 4.53% | 4.79% | 4.50% | Upgrade
|
FCF Yield | -0.11% | -0.12% | -0.13% | 1.49% | -2.34% | 0.30% | Upgrade
|
Dividend Yield | 0.78% | 0.79% | 0.95% | 0.77% | 0.67% | 0.47% | Upgrade
|
Payout Ratio | 16.01% | 16.01% | 19.05% | 13.72% | 14.11% | 8.38% | Upgrade
|
Buyback Yield / Dilution | -0.02% | -0.02% | -0.05% | 0.00% | 0.00% | 0.00% | Upgrade
|
Total Shareholder Return | 0.77% | 0.77% | 0.90% | 0.77% | 0.67% | 0.47% | Upgrade
|
Updated Jan 14, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.